Oscar D Rangel-Huerta1, Angel Gil1,2. 1. Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, Biomedical Research Centre, University of Granada, Granada, Spain. 2. Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Abstract
Context: The increasing number of studies on the effects of n-3 long-chain polyunsaturated fatty acids (LC-PUFAs) on health, particularly cognition, in the last 5 years reflects the growing interest in this area of research. Objective: The aim for this systematic review was to evaluate the scientific evidence published in the last 5 years (2012-2017) on the effects of n-3 LC-PUFA intake on cognition, cognitive development, and cognitive decline to determine whether n-3 LC-PUFAs support cognitive development and prevent cognitive decline. Data Sources: The PubMed database was searched. Study Selection: The 51 articles included in this systematic review reported on healthy individuals with mild or moderate cognitive impairment and patients with Alzheimer's disease. Risk of bias was assessed using Cochrane methodology. Data Extraction: The number of study participants, the type of study, the type and dose of n-3 LC-PUFAs, and the key results are reported here. Results: Current evidence indicates that n-3 LC-PUFAs administered during pregnancy or breastfeeding have no effect on the skills or cognitive development of children in later stages of development. Evidence regarding the improvement of cognitive function during childhood and youth or in attention deficit/hyperactivity disorder is inconclusive. Moreover, it is still unclear if n-3 LC-PUFAs can improve cognitive development or prevent cognitive decline in young or older adults.
Context: The increasing number of studies on the effects of n-3 long-chain polyunsaturated fatty acids (LC-PUFAs) on health, particularly cognition, in the last 5 years reflects the growing interest in this area of research. Objective: The aim for this systematic review was to evaluate the scientific evidence published in the last 5 years (2012-2017) on the effects of n-3 LC-PUFA intake on cognition, cognitive development, and cognitive decline to determine whether n-3 LC-PUFAs support cognitive development and prevent cognitive decline. Data Sources: The PubMed database was searched. Study Selection: The 51 articles included in this systematic review reported on healthy individuals with mild or moderate cognitive impairment and patients with Alzheimer's disease. Risk of bias was assessed using Cochrane methodology. Data Extraction: The number of study participants, the type of study, the type and dose of n-3 LC-PUFAs, and the key results are reported here. Results: Current evidence indicates that n-3 LC-PUFAs administered during pregnancy or breastfeeding have no effect on the skills or cognitive development of children in later stages of development. Evidence regarding the improvement of cognitive function during childhood and youth or in attention deficit/hyperactivity disorder is inconclusive. Moreover, it is still unclear if n-3 LC-PUFAs can improve cognitive development or prevent cognitive decline in young or older adults.
Authors: Julie E H Nevins; Sharon M Donovan; Linda Snetselaar; Kathryn G Dewey; Rachel Novotny; Jamie Stang; Elsie M Taveras; Ronald E Kleinman; Regan L Bailey; Ramkripa Raghavan; Sara R Scinto-Madonich; Sudha Venkatramanan; Gisela Butera; Nancy Terry; Jean Altman; Meghan Adler; Julie E Obbagy; Eve E Stoody; Janet de Jesus Journal: J Nutr Date: 2021-11-02 Impact factor: 4.687
Authors: Rebecca L Cook; Helen M Parker; Cheyne E Donges; Nicholas J O'Dwyer; Hoi Lun Cheng; Katharine S Steinbeck; Eka P Cox; Janet L Franklin; Manohar L Garg; Helen T O'Connor Journal: Lipids Health Dis Date: 2019-11-06 Impact factor: 3.876
Authors: Lidia Daimiel; Miguel A Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Helmut Schröder; Jesús Vioque; Dora Romaguera; J Alfredo Martínez; Julia Wärnberg; Jose Lopez-Miranda; Ramón Estruch; Naomi Cano-Ibáñez; Angel Alonso-Gómez; Josep A Tur; Francisco J Tinahones; Lluis Serra-Majem; Rafael M Micó-Pérez; José Lapetra; Alba Galdón; Xavier Pintó; Josep Vidal; Victor Micó; Gonzalo Colmenarejo; José J Gaforio; Pilar Matía; Emilio Ros; Pilar Buil-Cosiales; Zenaida Vázquez-Ruiz; José V Sorlí; Indira Paz Graniel; Aida Cuenca-Royo; Cristina Gisbert-Sellés; Aina M Galmes-Panades; M Angeles Zulet; Antonio García-Ríos; Andrés Díaz-López; Rafael de la Torre; Iñigo Galilea-Zabalza; José M Ordovás Journal: Sci Rep Date: 2020-02-26 Impact factor: 4.379
Authors: Xuanxia Mao; Cheng Chen; Pengcheng Xun; Martha Daviglus; Lyn M Steffen; David R Jacobs; Linda Van Horn; Stephen Sidney; Na Zhu; Ka He Journal: Nutrition Date: 2018-11-24 Impact factor: 4.893
Authors: Dorien H Nieman; UnYoung Chavez-Baldini; Nienke C Vulink; Dirk J A Smit; Guido van Wingen; Pelle de Koning; Arjen L Sutterland; Roel J T Mocking; Claudi Bockting; Karin J H Verweij; Anja Lok; Damiaan Denys Journal: BMC Psychiatry Date: 2020-05-11 Impact factor: 3.630